Home Carboxes 71233-25-5
71233-25-5,MFCD09878815
Catalog No.:AA0032RA

71233-25-5 | 3-Oxo-piperidine-1,4-dicarboxylic acid 1-tert-butyl ester 4-ethyl ester

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
97%
in stock  
$11.00   $8.00
- +
5g
≥97%
in stock  
$19.00   $13.00
- +
10g
97%
in stock  
$25.00   $18.00
- +
25g
≥97%
in stock  
$59.00   $42.00
- +
100g
97%
in stock  
$173.00   $121.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA0032RA
Chemical Name:
3-Oxo-piperidine-1,4-dicarboxylic acid 1-tert-butyl ester 4-ethyl ester
CAS Number:
71233-25-5
Molecular Formula:
C13H21NO5
Molecular Weight:
271.3095
MDL Number:
MFCD09878815
SMILES:
CCOC(=O)C1CCN(CC1=O)C(=O)OC(C)(C)C
Properties
Properties
 
Form:
Liquid  
Storage:
Inert atmosphere;2-8℃;  

Computed Properties
 
Complexity:
372  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
5  
Rotatable Bond Count:
5  
Undefined Atom Stereocenter Count:
1  
XLogP3:
1.5  

Upstream Synthesis Route

[1]Synthesis,2011,#8,p.1208-1212

[2]Patent:WO2015/124941,2015,A1,.Locationinpatent:Page/Pagecolumn134

[3]Patent:US2002/19388,2002,A1,

[4]Patent:WO2008/130581,2008,A1,.Locationinpatent:Page/Pagecolumn161;171

[5]Patent:WO2007/15162,2007,A1,.Locationinpatent:Page/Pagecolumn85

[6]Patent:US2009/325948,2009,A1,.Locationinpatent:Page/Pagecolumn92

[7]JournalofMedicinalChemistry,2006,vol.49,#26,p.7843-7853

[8]Patent:US5965578,1999,A,

[9]Patent:US2005/65178,2005,A1,.Locationinpatent:Page/Pagecolumn20

[10]Patent:CN107188894,2017,A,.Locationinpatent:Paragraph0006;0007;0018

[1]Patent:WO2011/29842,2011,A1,.Locationinpatent:Page/Pagecolumn40

[2]ACSMedicinalChemistryLetters,2013,vol.4,#2,p.186-190

[3]Patent:WO2015/124941,2015,A1,.Locationinpatent:Page/Pagecolumn133;134

[4]Patent:WO2011/50200,2011,A1,.Locationinpatent:Page/Pagecolumn45

[5]Patent:WO2011/50202,2011,A1,.Locationinpatent:Page/Pagecolumn44

[6]Patent:US2005/101602,2005,A1,.Locationinpatent:Page/Pagecolumn26

[7]Patent:WO2011/103091,2011,A1,.Locationinpatent:Page/Pagecolumn88-89

[8]Patent:WO2013/185084,2013,A1,.Locationinpatent:Paragraph0102

[1]ACSMedicinalChemistryLetters,2013,vol.4,#2,p.186-190

[2]Patent:WO2013/185084,2013,A1,.Locationinpatent:Paragraph0084

[3]Patent:WO2010/53438,2010,A1,.Locationinpatent:Page/Pagecolumn58;59

[4]JournalofLabelledCompoundsandRadiopharmaceuticals,1999,vol.42,#SUPPL.1,p.S762-S764

[5]JournalofLabelledCompoundsandRadiopharmaceuticals,2001,vol.44,p.S254-S256

[6]BioorganicandMedicinalChemistryLetters,2005,vol.15,#18,p.4023-4028

[7]JournalofMedicinalChemistry,2006,vol.49,#15,p.4544-4567

[8]Patent:US2003/32654,2003,A1,

[1]ArchivderPharmazie,2010,vol.343,#3,p.143-151

[2]Patent:US2003/236250,2003,A1,.Locationinpatent:Page32

[3]TetrahedronAsymmetry,2004,vol.15,#20,p.3281-3287

[4]EuropeanJournalofMedicinalChemistry,2011,vol.46,#6,p.2421-2426

[1]Patent:WO2010/123919,2010,A2,.Locationinpatent:Page/Pagecolumn60

Downstream Synthesis Route
71233-25-5   
6-tert-butoxycarbonyl-3-oxo-2,3,4,5,6,7-hexahydropyrazolo<3,4-c>pyridine 

[1]Patent:US2014/275015,2014,A1.Locationinpatent:Paragraph0612

[2]Tetrahedron,1991,vol.50,p.515-528

[1]ACSMedicinalChemistryLetters,2013,vol.4,p.186-190

[2]Patent:WO2013/185084,2013,A1.Locationinpatent:Paragraph0084

[3]Patent:WO2010/53438,2010,A1.Locationinpatent:Page/Pagecolumn58;59

[4]Journaloflabelledcompoundsandradiopharmaceuticals,1999,vol.42,p.S762-S764

[5]Journaloflabelledcompoundsandradiopharmaceuticals,2001,vol.44,p.S254-S256

[6]BioorganicandMedicinalChemistryLetters,2005,vol.15,p.4023-4028

[7]JournalofMedicinalChemistry,2006,vol.49,p.4544-4567

[8]Patent:US2003/32654,2003,A1

[1]JournalofMedicinalChemistry,2006,vol.49,p.4544-4567

[2]BioorganicandMedicinalChemistryLetters,2013,vol.23,p.1754-1759

[3]Journaloflabelledcompoundsandradiopharmaceuticals,1999,vol.42,p.S762-S764

[4]Patent:EP3567030,2019,A1.Locationinpatent:Paragraph0232-0233

[1]Patent:US2002/19388,2002,A1

[2]Journaloflabelledcompoundsandradiopharmaceuticals,2001,vol.44,p.S254-S256

24424-99-5   
ethyl3-oxopiperidine-4-carboxylatehydrochloride 
  71233-25-5 

[1]ArchivderPharmazie,2010,vol.343,p.143-151

[2]Patent:US2003/236250,2003,A1.Locationinpatent:Page32

[3]TetrahedronAsymmetry,2004,vol.15,p.3281-3287

[4]EuropeanJournalofMedicinalChemistry,2011,vol.46,p.2421-2426

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:71233-25-5 Molecular Formula|71233-25-5 MDL|71233-25-5 SMILES|71233-25-5 3-Oxo-piperidine-1,4-dicarboxylic acid 1-tert-butyl ester 4-ethyl ester